Expert Q&A

Jan Komrska and Ishmael Qawiy, Pharmacists for the Research Division at Vital Strategies discuss the significance of clinical trial supply chain management, how COVID-19 is affecting them and ways in which they can be strengthened.

We sat down with Katie Merritt, our Overdose Prevention and Response Coordinator to learn more about the governor’s strategic plan, the focus on harm reduction, and Vital Strategies’ work to reduce overdose deaths.

Daliah Heller, Director of Drug Use Initiatives at Vital Strategies discusses how COVID-19 has impacted people who use drugs and how states can encourage harm reduction during the pandemic.

On January 27, Vital Strategies’ Overdose Prevention Program hosted a naloxone training in our New York office to educate staff on the opioid epidemic and what they can do in their communities to prevent fatal overdose and help save lives. We sat down with Esther Mae Rosner, Program Officer of Vital Strategies’ Overdose Prevention Program, to learn more about naloxone and the importance of these trainings.

While TB incidence has slowly declined in recent years, there is still a significant need to identify, treat, and prevent this disease.

More than 92% of the world’s population is exposed to poor air quality. Air pollution is the fifth leading risk factor for death and accounts for more than 5 million deaths each year globally.

We sat down with Daliah Heller, Director of Drug Use Initiatives at Vital Strategies, to get her thoughts on what actions can be taken to reverse the country’s drug overdose crisis.

The majority of countries simply don’t know how many children are being exposed, or how severe the exposure is. Many are ill-equipped to enforce regulations in consumer products. And, mining industries are politically powerful and exploit perceptions that development needs trump environmental health concerns.

What are some of the obstacles that women face with regard to registration in some countries? There are a number of issues:…